Curated News
By: NewsRamp Editorial Staff
August 31, 2026
Earth Science Tech Acquires Zoolzy to Boost Margins and Expand Verticals
TLDR
- Earth Science Tech's Zoolzy acquisition secures competitive wholesale pricing on APIs, boosting profit margins and market advantage.
- Earth Science Tech acquired Zoolzy LLC, a wholesale distributor of APIs and FDA-approved products, to integrate supply chain and expand verticals.
- The acquisition enables Earth Science Tech to provide broader access to essential medications and veterinary care, improving health outcomes.
- Earth Science Tech's Zoolzy deal marks a strategic entry into the veterinary market, adding a new growth dimension.
Impact - Why it Matters
This acquisition matters because it strengthens Earth Science Tech's position in the pharmaceutical supply chain, potentially leading to lower costs and higher profitability. For investors, it signals strategic expansion into new markets like veterinary pharmaceuticals, which could drive future revenue growth. For the broader healthcare industry, it demonstrates a trend of vertical integration that may improve efficiency and availability of prescription products.
Summary
Earth Science Tech (OTC: ETST), a strategic holding company in the healthcare, pharmacy, and telemedicine sector, has completed the acquisition of Zoolzy LLC, a wholesale distributor of active pharmaceutical ingredients (APIs) and finished FDA-approved prescription products. Based in Doral, Florida, Zoolzy operates from a 3,684-square-foot facility. The acquisition is a key move to expand Earth Science Tech’s telehealth and pharmacy fulfillment platforms into new, complementary verticals, and it delivers value across three growth drivers: expanding overall profit margins, broadening access to new ingredients, and enabling entry into the veterinary market.
By integrating Zoolzy, Earth Science Tech’s compounding pharmacies can secure essential raw materials at highly competitive wholesale pricing, which is expected to significantly increase profit margins. The acquisition also opens doors to a wider range of ingredients, enhancing the company’s product offerings and flexibility. Moreover, it paves the way for Earth Science Tech to enter the veterinary market, a sector with substantial growth potential. This strategic acquisition positions the company to seize opportunities in the healthcare supply chain, strengthen its competitive edge, and better serve its clients.
Investors and stakeholders can find more details in the Earth Science Tech newsroom and the full press release. The move aligns with the company’s mission to become a leading player in the healthcare ecosystem, leveraging Zoolzy’s distribution capabilities to enhance operational efficiency and market reach. As Earth Science Tech continues to diversify, this acquisition is a testament to its commitment to innovation and growth.
Source Statement
This curated news summary relied on content distributed by InvestorBrandNetwork (IBN). Read the original source here, Earth Science Tech Acquires Zoolzy to Boost Margins and Expand Verticals
